Company
Headquarters: Beijing, China
Employees: 450
HK$127.3 Million
HKD as of Jan. 1, 2024
US$16.3 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $207.62 B |
| Danaher | $171.89 B |
| Siemens Healthineers AG | $66.05 B |
| DexCom, Inc. | $46.50 B |
| IDEXX Laboratories, Inc. | $44.72 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagent products primarily in Mainland China. It offers clinical chemistry reagents, including single and double reagents, calibrators, quality control products, and washing solution detergents; flow cytometers and bio chemical analyzers; time-resolved fluoroimmunoassay analyzers; Elisa kits; and rapid tests. The company also provides medical and medical inspection services; produces medical instruments; and distributes immunodiagnostic products, biological reagents, and instruments. Biosino Bio-Technology and Science Incorporation was founded in 1988 and is based in Beijing, China.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Biosino Bio-Technology and Science InCorp has the following listings and related stock indices.
Stock: HKEX: 8247 wb_incandescent